• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24

    12/1/24 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care
    Get the next $PHG alert in real time by email

    December 1, 2024

    Philips' intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging for a greater number of patients

    Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today unveiled the company's latest AI-powered diagnostic and treatment imaging innovations to advance precise imaging with faster, easier and more efficient workflows. Addressing key challenges faced by radiologists, these innovations are complemented by Philips' industry-leading expertise in cloud-based data management, advanced visualization, automation, and AI. Together, they aim to reduce the administrative burden and empower clinicians with insights to deliver better care for more people.

    "The healthcare industry is facing a perfect storm of challenges in radiology: increasing patient volumes, skyrocketing demand for imaging studies, and an explosion in imaging data. At the same time, staff shortages are creating mounting pressure on already strained resources," said Bert van Meurs, Chief Business Leader of Diagnosis and Treatment at Philips. "Our intelligent imaging systems combined with our world-class informatics support healthcare providers in embracing innovative solutions that enhance efficiency, reduce the administrative burden, and empower radiologists to focus on delivering precise, high-quality care."

    The Philips Future Health Index 2024 Report shows 99% of radiology leaders surveyed struggle with staff shortages, with nearly 4 in 5 facing financial pressures, and 45% experiencing symptoms of burnout. Radiologists are also seeing a 40% increase in patients with complex diseases [1] in clinical areas like cardiology and neurology, which is driving the need for imaging exams and a 60% increase in imaging data [2]. At this year's RSNA, Philips will demonstrate how it is uniquely positioned to help mitigate these challenges with breakthrough innovations that advance precision imaging for more patients and enhance productivity through seamless integration of imaging and informatics.

    Leadership in innovative helium-free MRI operations

    Philips will unveil the industry's first and only wide-bore, high-performance helium-free [3] MR scanner with fully integrated cloud-based, AI-driven, automated quantitative reporting capabilities [4] for specific disease areas like neurology and oncology. With AI assistance at every step of the workflow, from planning to imaging and reporting, Philips' next generation BlueSeal 1.5T MRI boosts productivity, ease of use and access to precision diagnosis around the world, while caring for the planet. Philips' revolutionary BlueSeal technology sets new standards in MRI as the lightest 70 cm system available today [5], making it easier to install and cost-effective to maintain, enabling flexible installations and wider access in new locations.

    Breakthrough innovations in Diagnosis and Treatment

    Making its debut in North America at RSNA is the fully AI-enabled CT 5300, featuring Precise Image AI-based reconstruction software to assist at every step of the CT workflow, while reducing radiation dose and improving image quality for complex exams like cardiac imaging. Philips will also spotlight Spectral CT 7500, providing spectral CT solutions across a wide range of clinical areas including cardiology, oncology, neurology, musculoskeletal, and pediatrics. With more than 24 million spectral exams performed to date, Spectral CT 7500 has been shown to deliver up to 97% diagnostic sensitivity compared to 55% with conventional CT [6]; 96% certainty of cyst vs. lesion compared to 30% with conventional CT [7]; and a 26% reduction in follow-up scans due to incomplete diagnosis [8].

    Philips is elevating image quality in ultrasound with the newest releases of its EPIQ Elite and Affiniti systems featuring new workflow and quantification automation to make exams faster and reproducible to help increase clinical confidence. With more than 100 optimized presets across multiple clinical applications, Philips' latest innovations in ultrasound help reduce exam times and variability. This is meant to increase efficiency with over 50% reduction in time for image optimization during abdominal and obstetrics exams [9].  Also showcased will be the latest Azurion 7 platform to support image-guided interventional procedures with a 17% reduction in procedure time and a 12% reduction in patient preparation time, bringing the ability to treat one more patient per day [10]. 

    Expanded strategic collaboration with AWS

    At RSNA Philips will showcase its advanced Healthcare Informatics capabilities for data management, advanced visualization, automation, and AI to help reduce administrative burdens and empower clinicians with insights to deliver better care. In the run-up to the event, Philips expanded its strategic collaboration with Amazon Web Services (AWS) to offer Philips' integrated diagnostics portfolio in the cloud, including radiology, digital pathology, cardiology [11], and AI advanced visualization [11] solutions. As part of the agreement, Philips aims to create robust and scalable generative AI applications that leverage state-of-the-art foundation models from Amazon Bedrock, and seamlessly integrate into clinical workflows.

    Philips will also debut the latest 510(k) clearance of its Radiology Operations Command Center remote scanning and remote protocol management features [12] enabling real-time collaboration between imaging experts and on-site technologists, virtually anywhere, to help streamline radiology operations and workflows to provide high-quality imaging to more patients at lower costs. Paired with the world's first and only helium-free mobile MRI solution, Philips continues to expand quality care to large populations of traditionally underserved patients in a more accessible and sustainable way.   

    Visit Philips at RSNA for more information.

    [1] 3 Key market trends source: The Burden of Chronic Disease (Karen Hacker); The healthcare data explosion (RBC Capital Markets); Radiologist burnout (Catalina imaging)

    [2] 3 Key market trends source: The Burden of Chronic Disease (Karen Hacker); The healthcare data explosion (RBC Capital Markets); Radiologist burnout (Catalina imaging)

    [3] Helium-free operations. 7 liters of helium is permanently enclosed in the cryogenic circuit.

    [4] BlueSeal XE/SE and Smart Reading are not yet CE marked, not cleared in all countries, and not yet available for delivery in any country. Please consult your Philips contact person for further information.

    [5] Compared to conventional 1.5T zero boil off systems in the industry BlueSeal MR system weight (with cryogen) 2,300 kg (5,071 lbs).

    [6] Mellander, et al. (Skåne University Hospital, Lund, Sweden), Acta Radiology (2022) DOI: 10.1177/02841851221130612

    [7] Andersen MB, Ebbesen D, Thygesen J, Kruis M, Rasmussen F. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol. 2020 Oct;30(10):5539-5550. doi: 10.1007/s00330-020-06878-7

    [8] Follow-up Recommendation Rates Associated with Spectral Detector Dual-Energy CT of the Abdomen and Pelvis: A Retrospective Comparison to Single-Energy CT. Atwi, Noah E. et al. J Am Coll Radiol. 2020;17:940-950

    [9] D001833994, Marketing Claim Evidence for VM12.0 Workflow Efficiency Quick Launch Preset

    [10] Results from study conducted at St. Antonius Hospital. Results verified by NAMSA, independent third-party expert on study design and analytics. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.

    [11] Available on cloud in 2025.

    [11] Available on cloud in 2025.

    [12] Remote editing and protocol management are functionalities powered by the 510(k) cleared ROCC Console solution. ROCC Console is not to be used without a trained and qualified user at the scanner.

    For further information, please contact:

    Kathy O'Reilly

    Philips Global External Relations

    Tel.: +1 978-221-8919

    E-mail : [email protected]

    About Royal Philips

    Royal Philips (NYSE:PHG, AEX: PHIA)) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

    Attachments

    • philips-next-gen-blueseal-mri-2
    • ct-5300-product-image-2
    • next-gen-blueseal-mri-with-smart-reading


    Primary Logo

    Get the next $PHG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • What advancements is Philips making in healthcare technology?

      Philips is leveraging AI-powered diagnostic and treatment imaging innovations to streamline workflows and enhance the efficiency of healthcare delivery.

    • What are the key challenges currently faced by radiology leaders according to the Philips report?

      The Philips Future Health Index 2024 Report indicates that 99% of radiology leaders face staff shortages and nearly 80% are under financial pressure, with growing patient volumes exacerbating the challenges in radiology.

    • What is unique about Philips' new MR scanner technology?

      Philips has unveiled the industry's first helium-free, high-performance MR scanner, aiming to increase accessibility and sustainability in MRI operations.

    • What features does the new AI-enabled CT 5300 offer to enhance diagnostic imaging?

      The AI-enabled CT 5300 is designed to assist throughout the CT workflow, reducing radiation dose while improving image quality, particularly for complex exams.

    • What strategic initiatives has Philips launched in collaboration with AWS to improve healthcare informatics?

      Philips expanded its collaboration with AWS to integrate its diagnostic solutions in the cloud, enhancing efficiency and supporting real-time collaboration in radiology operations.

    Recent Analyst Ratings for
    $PHG

    DatePrice TargetRatingAnalyst
    2/25/2025Neutral → Outperform
    Exane BNP Paribas
    2/20/2025Neutral → Buy
    UBS
    10/29/2024Underperform → Hold
    Jefferies
    5/13/2024Mkt Perform → Outperform
    Bernstein
    5/7/2024Underperform → Neutral
    Exane BNP Paribas
    4/30/2024Sell → Neutral
    UBS
    4/30/2024Underweight → Neutral
    JP Morgan
    2/7/2024Outperform → Underperform
    Exane BNP Paribas
    More analyst ratings

    $PHG
    Leadership Updates

    Live Leadership Updates

    See more
    • Philips shareholders approve all proposals at the AGM 2025

      May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board.The appointment of Mr Bob White as a new member of the Supervisory Board.The re-appointment of Mr Marnix van Ginneken as member of the Board of Management. The discharge of the members of the Board of Management, and of the members of the Supervisory Board.A full overview of the resolutions taken at the AGM 2025 can be found below. Feike Sijbesma, Chairman of Philips' Supervisory Board, sa

      5/8/25 12:16:51 PM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips proposes new Supervisory Board appointments and reappointments, and Board of Management reappointment

      Mr David Pyott to retire from Philips' Supervisory Board after his third consecutive term.Mr Bob White proposed as new member of the Supervisory Board.Ms Indra Nooyi and Ms Chua Sock Koong proposed for reappointment as members of the Supervisory Board.Mr Marnix van Ginneken proposed for reappointment as member of Philips' Board of Management. February 19, 2025Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced proposed Supervisory Board appointments and reappointments, and a proposed Board of Management reappointment. Mr David Pyott (British/American, 1953) will retire from Philips' Supervisory Board at the end of the Annu

      2/19/25 1:05:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region

      January 9, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced the appointment of Jie Xue as Chief Business Leader Precision Diagnosis, and Özlem Fidanci as Chief of International Region, both effective January 1, 2025. Ms. Xue and Ms. Fidanci have joined Philips' Executive Committee and report directly to Roy Jakobs, CEO of Philips.Ms. Xue joins Philips from GE Healthcare to lead the Precision Diagnosis business that was temporarily led by Bert van Meurs, who will continue to lead Philips' Image Guided Therapy business. Ms. Xue and Mr. Van Meurs will be jointly responsible for the Diagnosis & Treatment segment. Ms. F

      1/9/25 4:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care

    $PHG
    Financials

    Live finance-specific insights

    See more

    $PHG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Philips announces exchange ratio for 2024 dividend

      June 5, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that the exchange ratio for the dividend for the year 2024 is 1 new common share for every 23.6353 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 30, June 2, and 3, 2025, of EUR 20.0600 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 22,980,748 new common shares. Shareholders have been given the opportunity to make their choice between a dividend in shares or (subject to certain conditions) in cash. The aggregate cash election

      6/5/25 4:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips delivers on Q1 results, with ongoing order intake growth

      May 6, 2025Q1 2025 Group performance Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty phasingComparable order intake increased 2% despite China declineIncome from operations increased to EUR 154 millionAdjusted EBITA margin declined 80 bps to 8.6% of sales, driven by sales phasingFree cash outflow of EUR 1,091 million included EUR 1,025 million payment for Philips Respironics recall-related medical monitoring and personal injury settlements in USUpdated full year 2025 outlook for Adjusted EBITA margin and free cash flow; sales outlook remains unchanged Roy Jakobs,

      5/6/25 1:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips convenes the Annual General Meeting of Shareholders 2025

      March 24, 2025Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes.As previously announced, the agenda includes: Proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025.Proposals to re-appoint Ms Indra Nooyi (American, 1955) and Ms Chua Sock Koong (Singaporean, 1957) as members of the Supervisory Board, with effect from May 8, 2025.Proposal to re-appoint Mr Marnix van Ginneken (Dutch, 1973) as a member of the Philips Board of Management, with effect from May 8, 2025.  The agenda fu

      3/24/25 4:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people

      In 2024, Philips Foundation initiated 22 new projects and 5 new impact investments expanding its impact and reach in innovative healthcare delivery to India and South AmericaCelebrating a decade of impact with strong progress towards the Foundation's 2030 goal to improve access to healthcare for 100 million people in underserved communities a yearThe combined impact of longstanding strategic collaborations and new innovative partnerships with healthcare ventures affirm the Foundation's approach to locally embedded innovation with flexible financing models to improve healthcare access Amsterdam, the Netherlands – Marking its tenth anniversary, Philips Foundation today released its 2024 Annua

      6/5/25 6:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips announces exchange ratio for 2024 dividend

      June 5, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that the exchange ratio for the dividend for the year 2024 is 1 new common share for every 23.6353 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 30, June 2, and 3, 2025, of EUR 20.0600 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 22,980,748 new common shares. Shareholders have been given the opportunity to make their choice between a dividend in shares or (subject to certain conditions) in cash. The aggregate cash election

      6/5/25 4:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips to repurchase up to 6 million shares to cover long-term incentive plans

      June 4, 2025  Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)) today announced that it will repurchase up to 6 million shares to cover certain of its obligations arising from its long-term incentive plans. At the current share price, the shares represent an amount of up to approximately EUR 125 million. The repurchases will be executed through one or more individual forward transactions, to be entered into in the course of the second and third quarter of 2025, in accordance with the Market Abuse Regulation and within the limits of the authorization granted by the company's General Meeting of Shareholders on May 8, 2025. Philips expects to take delivery of the shares in 202

      6/4/25 3:00:00 AM ET
      $PHG
      Medical Electronics
      Health Care

    $PHG
    SEC Filings

    See more
    • SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

      6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

      6/5/25 7:25:39 AM ET
      $PHG
      Medical Electronics
      Health Care
    • SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

      6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

      6/4/25 9:44:19 AM ET
      $PHG
      Medical Electronics
      Health Care
    • SEC Form SD filed by Koninklijke Philips N.V. NY Registry Shares

      SD - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

      5/28/25 11:09:45 AM ET
      $PHG
      Medical Electronics
      Health Care

    $PHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Philips upgraded by Exane BNP Paribas

      Exane BNP Paribas upgraded Philips from Neutral to Outperform

      2/25/25 7:12:36 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips upgraded by UBS

      UBS upgraded Philips from Neutral to Buy

      2/20/25 7:05:01 AM ET
      $PHG
      Medical Electronics
      Health Care
    • Philips upgraded by Jefferies

      Jefferies upgraded Philips from Underperform to Hold

      10/29/24 6:28:08 AM ET
      $PHG
      Medical Electronics
      Health Care

    $PHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares

      SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

      6/25/24 4:35:57 PM ET
      $PHG
      Medical Electronics
      Health Care
    • SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares (Amendment)

      SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

      5/16/24 5:52:57 PM ET
      $PHG
      Medical Electronics
      Health Care
    • SEC Form SC 13D filed by Koninklijke Philips N.V. NY Registry Shares

      SC 13D - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

      8/23/23 12:44:28 PM ET
      $PHG
      Medical Electronics
      Health Care